Comparison of Topical Corticosteroid (TCS) Phobia levels among Preclinical and Clinical Years Medical Students: Using TOPICOP Score
DOI:
https://doi.org/10.21649/akemu.v30i4.5646Keywords:
Corticosteroids, Corticosteroid phobia, Medical students, Pharmacology & TherapeuticsAbstract
Background: Corticosteroid medications are commonly used in various medical conditions due to their potent anti-inflammatory and immunosuppressive properties. However, corticosteroid phobia, which refers to the fear to use these medications, can impact their appropriate use in clinical practice.
Objective: This study aimed to compare the level of Topical corticosteroid (TCS) phobia among pre-clinical and clinical year medical students by using TOPICOP score.
Methods: A cross-sectional study was conducted, after obtaining ethical approval, among MBBS students. A pre-tested questionnaire was used to assess TCS phobia, which included knowledge, attitudes, and beliefs about corticosteroids, as well as comfort level in prescribing or administering these in hypothetical clinical scenarios. Data was analyzed using descriptive and inferential statistics, including chi-square test.
Results: The study surveyed 286 medical students; 139 of them were Pre-Clinical years students (48.6%), while 147 in Clinical (51.4%). Mean age in Pre-Clinical years was 18.7+1.2 while 21.2+2.8 in Clinical years & 51.4% reported studying pharmacology, which is the subject educating most on the various effects of TCS. Significant findings include: Clinical years students express more concern about TCS affecting future health (26.53% vs 14.39%); Clinical years students are more afraid of applying TCS on thinner skin areas (25.85% vs 21.58%); Clinical years students are more likely to stop TCS treatment early (26.53% vs 10.07%); Clinical years students are more inclined towards non-steroidal alternatives even if more expensive (25.17% vs 14.39%); and Clinical years students perceive more benefit from TCS use (21.09% vs 9.35%).
Conclusion: Our findings highlighted a greater sense of caution held by Clinical Years, regarding use of TCS and its potential side effects, while still appreciating its therapeutic role
References
Mohanna MT, Albeladi RA, Alshareef EK, Alsaedi SA, Aljawi AF, Ozbuk AA. Topical corticosteroid phobia among high educational students in Al-Madinah region: A cross-sectional study. Med Sci. 2023;27(1):1-10.
Contento M, Cline A, Russo M. Steroid Phobia: A Review of Prevalence, Risk Factors, and Interventions. Am J Clin Dermatol. 2021;22(6):837-51.
Mueller SM, Itin P, Vogt DR, Walter M, Lang U, Griffin LL, et al. Assessment of “corticophobia” as an indicator of non-adherence to topical corticosteroids: a pilot study. J Dermatolog Treat. 2017;28(2):104-11.
Masood S, Jalil P, Awan S, Ghulam U, Kerawala SR. Assessment of topical steroid phobia in dermatology patients, a cross-sectional study from an urban area of Pakistan. J Dermatolog Treat. 2022;33(4):2331-4.
Manar A. Alotaibi et al. Knowledge and phobias about the use of topical corticosteroids among the Saudi population: A cross-sectional study. World Fam Med J. 2022; 20(12): 6-16.
Song SY, Jung SY, Kim E. Steroid phobia among general users of topical steroids: a cross-sectional nationwide survey. J Dermatolog Treat. 2019;30(3):245-50.
Lambrechts L, Gilissen L, Morren M-A. Topical corticosteroid phobia among healthcare professionals using the TOPICOP score. Acta Derm Venereol. 2019;99(11):1004-8.
Lee JY, Her Y, Kim CW, Kim SS. Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea. ad. 2015;27(5):499-506.
Koster ES, Philbert D, Zheng X, Moradi N, de Vries TW, Bouvy ML. Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis. Int J Clin Pharm. 2021;43(5):1237-44.
Ozceker D, Uckun U, Islamova D, Tamay Z, Guler N. Corticosteroid phobia among parents of asthmatic children. Turk J Pediatr. 2018;60(2):142-6.
Barakat M, Elnaem MH, Al-Rawashdeh A, Othman B, Ibrahim S, Abdelaziz DH, et al. Assessment of Knowledge, Perception, Experience and Phobia toward Corticosteroids Use among the General Public in the Era of COVID-19: A Multinational Study. Healthcare (Basel). 2023;11(2):62-69.
Choi E, Tan KW, Tang F, Tan C, Chandran NS. Efficacy of targeted education in reducing topical steroid phobia: A randomised clinical trial. J A Acad Dermatol. 2020;83(6):1681-7.
Boonpuen N, Srimuang A, Puangpet P, Supsrisunjai C. Validity and reliability of the topical corticosteroid phobia (TOPICOP©) Questionnaire: Thai version. Siriraj Med J. 2023 ;75(2):115–20.
Choi E, Chandran N, Tan C. Corticosteroid Phobia: A questionnaire study using TOPICOP score. Singapore Med J. 2020;61(3):149–53.
Gupta M. Topical corticosteroid abuse among pediatric population – a prospective study. Our Dermatol Online. 2020;11(2):194–6.
Barakat M, Mansour NO, Hassan Elnaem M, Thiab S, Abu Farha R, Sallam M, et al. Evaluation of knowledge, experiences, and fear toward prescribing and dispensing corticosteroids among Egyptian healthcare professionals: A cross-sectional study. Saudi Pharm J. 2023;31(10):101777.
Alrohaimi Y, Alturki RA, Aljithalin AA, Alanazi RB, Almimony OL. Parent concern and awareness of corticosteroid use in pediatric patients with atopic dermatitis in al-majmaah, Saudi Arabia. PJMHS. 2022;16(5):1212–7.
Chiew Ping T, Ariffin AK, Jyh Jong T, Siddiqui S, Zainal H. Pharmacist’s knowledge about the safe use of TCS in atopic dermatitis: A pre–post-survey study evaluating the impact of TCS reading module. J Pharm Health Serv Res. 2023;14(3):343–51.
Fasih S, Arif AB, Amar A, Haque M ul, Hameed F, Iqbal J. Misuse of topical corticosteroids on facial skin [Internet]. Pak J Physiol. [cited 2024 Mar 2]. Available from: https://pjp.pps.org.pk/index.php/PJP/article/view/1239
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Annals of King Edward Medical University
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments publications@kemu.edu.pk